Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) said its fully owned Indian subsidiary, Predictmedix India Private Ltd, has engaged an Indian supplier for the mass production of AI-powered Safe Entry stations.
"We are thrilled to be partnering with our esteemed Indian supplier to accelerate the mass production and deployment of Safe Entry. We are aligning with a supplier that can rapidly deploy thousands of units in a compressed time frame," said Dr. Rahul Kushwah, COO of Predictmedix, in a statement.
"Their state-of-the-art facilities and expertise in manufacturing will play a pivotal role in our efforts to enhance public safety worldwide. This collaboration will enable us to reach a larger audience and make a significant impact in creating safer and more secure environments."
Safe Entry employs proprietary artificial intelligence (AI) algorithms and multisensory technology to detect various indicators that can help identify potential risks and enhance health, safety, and security protocols. The collaboration between Predictmedix AI and its Indian supplier is expected to yield substantial benefits.
Predictmedix AI is an emerging provider of rapid health screening and remote patient care solutions globally.
Contact the author at jon.hopkins@proactiveinvestors.com